FINWIRES · TerminalLIVE
FINWIRES

Bank of Montreal Price Target Raised to $230 at RBC

By

RBC Capital Markets raised its price target on Bank of Montreal (BMO.TO) to $230 from $205 on Thursday.

Analyst Darko Mihelic maintained a Sector Perform rating on shares of the Canadian bank following its quarterly results.

"BMO's Q2/26 results were stronger than expected across most segments, except for Canada," Mihelic said in a note to clients. "We see solid US results and model for better revenue/PPPT growth in that segment."

"BMO maintained its stage 3 (impaired) provision for credit loss (PCL) ratio guidance of mid-40s bps for the next few quarters and expects its impaired PCL ratio to improve to mid-30s bps by the end of 2027," the analyst said.

"We decrease our impaired PCL ratio estimates in 2027 to get closer to this guide as BMO's PCL was better than expected this quarter."

Related Articles

Research

Research Alert: Iclr: Q4 2025 Results Mixed After Long Delay; 2026 Guidance Headwinds

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ICON reported challenging Q4 results with sales of $2.11B (+2.5% Y/Y, $130M above consensus) but adjusted EPS of $2.52 fell $0.59 short of estimates and declined 26.5%. Full-year 2025 sales of $8.25B rose just 0.8%, while adjusted EBITDA margin contracted meaningfully to 18.6% (-180 bps), reflecting industry headwinds including elevated cancellations and pricing pressure. A bright spot was strong bookings momentum with $3.2B in Q4 gross wins supporting a robust 1.36 book-to-bill ratio, while the completed accounting investigation resulted in minimal revenue restatements of 0.8%-1.1% for 2023-2024 with no operational impact. For 2026, ICLR guided to revenue of $7.85B-$8.15B and EPS of $10.00-$11.00, representing declines of about 3% and 16%, respectively, at the midpoint. The guidance reflects continued near-term margin pressure and operational challenges, in our view, though management expressed confidence in large pharma spending recovery and improving biotech funding conditions.

$ICLR
Research

Research Alert: Hpq: Decent Q2, Driven By Price Increases; Fy 26 Guidance Largely Maintained

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HP's Q2 FY 26 results exceeded consensus with revenue of $14.41B (+9% Y/Y) vs. $14.07B estimate and non-GAAP EPS of $0.86 (+21%) vs. $0.72 consensus, with operating margin of 7.5% up 20 bps. Personal Systems grew 13% driven entirely by price increases while units declined 7%, and operating margin expanded 70 bps to 5.2% despite elevated component costs. We believe AI PC momentum provides upside as shipments reached 44% of mix (up from 35% prior quarter), though we expect consumer demand destruction as prices rise with memory/CPU costs. Management maintained FY 26 guidance with non-GAAP EPS of $3.00 midpoint, down from $3.05 but improved versus prior commentary, and free cash flow of $2.9B. We see downside to estimates given component price volatility, as recent price-increase-driven growth is likely unsustainable medium-term while Printing continues structural decline with revenue down 2% despite maintaining strong 18.3% operating margins.

$HPQ
Research

Research Alert: Everpure: Strong Q1 Results, But Presence Of Pull-ins Questions Sustainability

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Everpure reported Q1 FY 27 results above expectations with revenue of $1.05B (+35% Y/Y) vs consensus ~$1.00B and non-GAAP EPS of $0.47 (+62% Y/Y) vs consensus $0.40, accelerating from Q4's 20% growth pace. Non-GAAP operating margin expanded 450 bps Y/Y to 15.1%, while product revenue grew 55% Y/Y and subscription ARR reached $2B (+19% Y/Y). We view the results as concerning given management's estimate that pull-ins and price increases drove roughly 1/3 of Q1's Y/Y revenue growth, with limited visibility beyond this fiscal year. FY 27 guidance beat expectations with revenue midpoint of $4.46B (+22% Y/Y), up 300 bps from prior 19% outlook, though management noted it's too early to call for further upside. We expect further demand destruction and HDD share gains at flash memory's expense throughout FY 27 and FY 28 as pricing discrepancies widen, though results are being inflated in the interim by component cost pressures and customer pull-ins.

$P